BrainStorm Cell Therapeutics Inc (BCLI): Brainstorm Cell Therapeutics Now Covered...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	21
Posts	2070
Boards Moderated	0
Alias Born	02/09/2006

CHM_760

Re: None

Wednesday, 07/30/2014 8:17:42 AM

Wednesday, July 30, 2014 8:17:42 AM

Brainstorm Cell Therapeutics Now Covered by Maxim Group (BCLI)
(here's the rest of your "fake" news)... http://www.americanbankingnews.com/2014/07/30/brainstorm-cell-therapeutics-now-covered-by-maxim-group-bcli/

July 30th, 2014 • 0 comments • Filed Under • by ABMN Staff
Stock analysts at Maxim Group assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI) in a report issued on Wednesday. The firm set a “buy” rating and a $3.00 price target on the stock.

Brainstorm Cell Therapeutics (NASDAQ:BCLI) opened at 0.29 on Wednesday. Brainstorm Cell Therapeutics has a 52 week low of $0.10 and a 52 week high of $0.38. The stock has a 50-day moving average of $0.3 and a 200-day moving average of $0.28. The company’s market cap is $65.2 million.

BrainStorm Cell Therapeutics Inc is a biotechnology company developing autologous stem cell therapies for highly debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (NASDAQ:BCLI) (Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s disease (PD) and Spinal Cord Injury.